Detecting prostate cancer by the intracellular presence of prostate-specific antigen in macrophages, detected in peripheral blood samples by a flow cytometric technique.

Detecting prostate cancer by the intracellular presence of prostate-specific antigen in macrophages, detected in peripheral blood samples by a flow cytometric technique. - Intracellular PSA in activated macrophages

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON37430

Enrollment

150

Registered

2012-03-21

Start date

2013-03-01

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostate hypertrophia prostate carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - all men, who visit the department of urology with prostate complaints (in the period april 2012-july 2012) - by which a needle-biopsy is performed for histopathologic examination - signed informed consent

Exclusion criteria

Exclusion criteria: - proven prostate pathology

Design outcomes

Primary

Measure	Time frame
Detecting prostate cancer by the intracellular presence of prostate-specific antigen in macrophages, detected in peripheral blood samples by a flow cytometric technique.	—

Countries

Netherlands

Outcome results